CNS Metastases clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • IAM1363 in HER2 Cancers

    open to eligible people ages 18 years and up

    This is a Phase 1/1b open-label, multi-center dose escalation and dose optimization study designed to evaluate the safety and preliminary efficacy of IAM1363 in participants with advanced cancers that harbor HER2 alterations.

    at UCSD

Last updated: